Online citations, reference lists, and bibliographies.
← Back to Search

ERCP‐ And Endoscopic Sphincterotomy‐Induced Pancreatitis

S. Sherman, G. Lehman
Published 1991 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Acute pancreatitis may occur after the performance of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic sphincterotomy. During ERCP and endoscopic sphincterotomy, the pancreas is subjected to many types of potential injury—mechanical, chemical, hydrostatic, enzymatic, microbiological, allergic, and thermal. These factors may act independently or in concert to induce postprocedure pancreatitis. The potential role of each etiologic factor in the development of ERCP- and endoscopic sphincterotomy-induced pancreatitis is detailed. The management of this complication is reviewed. Patient factors that increase the risk for pancreatitis and techniques to prevent or limit this complication are described. A variety of agents have been shown to prevent or treat pancreatitis in animal models, but extrapolation to humans has been almost uniformly unsuccessful. Although postprocedure pancreatitis is unlikely to be completely eliminated, careful patient selection and attention to detail may reduce the incidence of this untoward event.
This paper references
10.1016/S0016-5085(76)80139-4
Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases.
Marcia K. Bilbao (1976)
10.2214/AJR.124.1.145
Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey.
W. Shehadi (1975)
Does somatostatin prevent acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation?
M Guelrud (1987)
10.1055/S-2007-1013024
Contrast media for ERCP.
A. Rambow (1988)
Effetti protettivi della somatostatina sul danno pancreatic0 da papillosfinterotomia chirurgica. Abstracts of the 85th Congress ofthe Societa Italiano Chirurgica
B Micah
Endoscopic sphincterotomy: the USA experience
FJ Tedesco (1984)
Preliminary results of a multicenter double blind trial of somatostatin (S) vs. placebo (P) in acute pancreatitis
J Moreau (1986)
10.1055/s-2007-1012959
Sepsis following injection of obstructed pancreatic ducts.
P. Ayela (1989)
10.1055/S-2007-1013018
A randomised, prospective study comparing two contrast media in ERCP.
W. Cunliffe (1987)
The mythology of acute pancreatitis
WM Keynes (1987)
10.1016/S0025-6196(12)61226-9
Low-osmolality contrast media: a current perspective.
B. King (1989)
The value of prophylactic antibiotic therapy during endoscopic retrograde cholangiopancreatography.
S. Hershey (1982)
Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
T. Wakayama (1989)
10.1097/00004836-198308000-00008
Prospective evaluation of the risk of bacteremia and the role of antibiotics in ERCP.
S. Dutta (1983)
Emergency endoscopic sphinctertomy in acute biliary pancreatitis: results of a multicenter study
J Escourrou (1987)
Risk factors for pancreatitis following ERCP: a prospective study
GB Haber (1987)
10.1136/gut.21.4.334
Morbidity of acute pancreatitis: the effect of aprotinin and glucagon.
(1980)
10.1148/123.3.585
A death following complications of roentgenologic nonoperative manipulation of common bile duct calculi.
E. Polack (1977)
10.1055/S-2007-1018176
Papillotomy and functional disorders of the sphincter of Oddi.
P. Krims (1988)
Endoscopic papillotomy--new indications, short- and long-term results.
M. Classen (1986)
10.1148/118.2.295
The normal endoscopic pancreatogram.
P. Varley (1976)
10.3109/00365528809093847
Experimental pancreatography: a comparison of three contrast media.
A. Saari (1988)
10.1016/S0016-5107(90)71115-7
Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter.
S. Sherman (1990)
10.1016/S0009-9260(82)80265-1
Metrizamide as contrast medium in endoscopic retrograde cholangio-pancreatography.
I. Hamilton (1982)
10.1055/S-2008-1040697
Newer endoscopic techniques for image diagnosis and management of hepatobiliary disease.
M. Classen (1982)
10.1002/BJS.1800710404
A study of endoscopic sphincterotomy in recurrent pyogenic cholangitis
S. K. Lam (1984)
Treatment of acute pancreatitis with somatostatin: results of a multicenter double blind trial
KH Usadel (1985)
Prophylactic effects 1955 $
E Matsunaga
Effects of somatostatin on clinical biochemical and morphological changes following ERCP
R Laugler (1984)
Resume of a seminar on endoscopic sphincterotomy (ERS)
J E Geenen (1981)
10.5555/URI:PII:0016508579902221
Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study.
H. Meshkinpour (1979)
10.1055/S-2007-1021593
Acute pancreatitis following gastrointestinal endoscopy without ampullary cannulation.
J. Deschamps (1982)
Idiopathic recurrent pancreatitis and hypercontractile sphincter of Oddi treatment with endoscopic sphincterotomy and pancreatic duct dilation
M Guelrud (1986)
Valutazioni cliniche e bio-umorali nell' impiego della somatostatina dopo interventi chirugici sulla sfera biliopancreatica. Abstracts of the 85th Congress of the Societa Italiano Chirurgica
P Pum
10.3109/00365527709181725
A comparison of a new non-ionic (metrizamide) and a dissociable (metrizoate) contrast medium in endoscopic retrograde pancreatography (ERP).
M. Osnes (1977)
10.3109/00365528309181642
Morphology of the pancreatic ductal epithelium after traumatization of the papilla of Vater or endoscopic retrograde pancreatography with various contrast media in cats.
H. Bub (1983)
Does somatostatin prevent acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation? Gastrointest Endosc 1987;33: 148A
M Guelrud (1987)
LEHMAN etration in pancreatic juice
P Pederzoli (1987)
10.1097/00000658-195604000-00012
Experimental Hemorrhagic Pancreatitis New Concepts of Pathogenesis
A. Stein (1956)
10.1016/S0016-5107(85)72197-9
ERCP and allergic reactions to iodized contrast media.
V. Moreira (1985)
10.1055/S-0028-1098340
ERCP and EPT: Italian experience.
A. Montori (1979)
10.1055/S-2007-1021589
Retroperitoneal perforations following endoscopic sphincterotomy; clinical course and management.
F. Dunham (1982)
Effetti protettivi della somatostatina sul danno pancreatic0 da papillosfinterotomia chirurgica
B Micah (1983)
impiego della somatostatina dopo interventi chirugici sulla sfera biliopancreatica. Abstracts of the 85th Congress of the Societa Italiano Chirurgica
G Tamas (1983)
Medical Research Council Working Party on the Treatment of Acute Pancreatitis. Death from acute pancreatitis
(1977)
10.1136/gut.17.2.127
Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography.
G. Skude (1976)
Prognostic signs and the role of operative management in acute pancreatitis.
John H. C. Ranson (1974)
Microstructure and ultrastructure of the human pancreas.
Y. Edlund (1957)
10.1002/BJS.1800680603
Endoscopic sphincterotomy: Indications and results
G. Viceconte (1981)
Is transduodenal pancreatography ever contraindicated?
A Galvan (1973)
10.1016/S0016-5107(75)73681-7
Complications associated with endoscopic retrograde cholangiopancreatography. Results of the 1974 A/S/G/E survey.
O. Nebel (1975)
A preliminary report: urgent duodenoscopic sphincterotomy for acute gallstone pancreatitis.
L. Safrany (1981)
Modifcation of endoscopic retrograde cholangiopancreatography (ERCP) septic complications by the addition of an antibiotic to the contrast media
MJ Colleen (1980)
10.1097/00004424-197911000-00008
Contrast absorption and pancreatic inflammation following experimental ERCP.
L. Kivisaari (1979)
10.3109/00365528909093111
Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs.
K. Ohlsson (1989)
10.1055/S-2007-1012903
New modalities for treating chronic pancreatitis.
H. Grimm (1989)
Planned operations for necrotizing pancreatitis: the continental experience
L F Hollender (1987)
Secretinkholecystokinin-stimulated secretion of trypsinogen and trypsin inhibitor in pure human pancreatic juice collected by endoscopic retrograde catheterizations
A Eddeland (1978)
[Effect of somatostatin on amylase level and pancreatitis rate following ERCP].
G. Börsch (1984)
10.1007/BF01855643
The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis
G. Balldin (1983)
Effect of perioperative somatostatin administration of sphincteroplasty-induced increase of amylase.
L. Roncoroni (1986)
10.1016/0022-4804(75)90016-5
Evaluation of prophylactic antibiotics in acute pancreatitis.
R. Howes (1975)
Pancreatitis secondary to endoscopic retrograde cholangiopancreatography (ERCP)
R C Olson
L'imprego della somatostatina dopo papilloplastica. Abstracts of the 85th Congress of the Societa Ztaliano Chirurgica
C Daposaniello
10.1097/00006676-198707000-00017
Recalcitrant pancreatitis: eventual control by antioxidants.
J. Braganza (1987)
10.1097/00000658-198510000-00002
lmproved Survival in 45 Patients with Pancreatic Abscess
A. Warshaw (1985)
Changes in serum levels of pancreatic isoamylase, lipase, trypsin, and elastase 1 after endoscopic retrograde pancreatography
奥野 優 (1985)
10.1055/S-2007-1013022
Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate.
H. J. O'Connor (1988)
Axon ATR. Metrizamide as contrast medium in endoscopic retrograde cholangiopancreatography
I Hamilton (1982)
Hoehler FK. Cimetidine in the treatment of acute alcoholic pancreatitis: a randomized double blind study
H Meshkinpour (1979)
10.1016/0002-9610(86)90006-1
Preoperative endoscopic retrograde cholangiopancreatography in the surgical management of pancreatic pseudocysts.
M. O'Connor (1986)
Pancreatitis or duodenal perforation after peri-Vaterian therapeutic endoscopic procedures: diagnosis, differentiation, and management.
M. Sarr (1986)
10.5555/URI:PII:0016508578903050
Medical treatment of acute pancreatitis: what is the evidence?
K. Soergel (1978)
Neuhaus B, Safrany L. Complications of endoscopic sphincterotomy and their treatment
Roberts-Thomson 1c (1981)
10.1056/NEJM198710013171401
Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material.
E. Lasser (1987)
10.1097/00000658-197711000-00018
Parenteral Nutrition inthe Treatment of Acute Pancr3eatitis: Effect on Complications and Mortality
J. Goodgame (1977)
10.1097/00000658-198402000-00005
Early or Delayed Endoscopic Papillotomy (EPT) in Gallstone Pancreatitis
A. Rosseland (1984)
10.1016/0016-5085(86)90587-1
Surgical intervention in necrotizing pancreatitis.
H. Reber (1986)
10.1016/0016-5085(87)90261-7
Early diagnosis of pancreatic infection by computed tomography-guided aspiration.
S. Gerzof (1987)
10.1055/S-2007-1018177
Balloon dilation of the sphincter of Oddi.
R. Kozarek (1988)
10.1148/RADIOLOGY.157.3.4059544
Post-ERCP pancreatitis: association with urographic visualization during ERCP.
M. Roszler (1985)
Radiology of acute pancreatitis: diagnosis, detection of complications and interventional therapy
P C Freeny
Pancreas preservation by somatostatin in patients undergoing ERCP examination
E Masi (1984)
Der einfluss von salm-calcitonin auf die enzyme und hormone des pankreas vor und nach retrograder choledochopankreatographie
EE Ohnhaus (1981)
Pancreatitis due to endoscopic biliary manometry: proceed with caution. Gastroenterology 1988;94:A227
CE King (1988)
Evaluation of atropine in acute pancreatitis.
J. Cameron (1979)
ERCP: Complications and prophylaxis a controlled study.
J. Brandes (1981)
10.1055/S-2007-1021682
Complications of Endoscopic Sphincterotomy and their Treatment
B. Neuhaus (1981)
creatitis following endoscopic retrograde cholangiopancreatography
(1983)
Acute pan-1979
I Hamilton
Pancreatic duct occlusion: a possible etiologic factor in pancreatitis post-ERCP and sphincter of Oddi manometry (SOM)
N Cohen (1989)
Complications of endoscopic sphincterotomy: computed tomographic evaluation
J E Kulman (1989)
10.1016/S0140-6736(78)92543-6
ENDOSCOPIC TREATMENT OF BILIARY-TRACT DISEASES: An International Study
L. Safrany (1978)
10.1016/S0016-5107(87)71517-X
Endoscopic sphincterotomy for suspected dysfunction of the sphincter of Oddi.
B. Thatcher (1987)
Pseudomonus infection of the biliary system from use of a contaminated endoscope
JI Allen (1987)
Is transduodenal pancreatography ever contraindicated? Gastrointest Endosc 1973;20:28-30
A Galvan (1973)
10.1016/0016-5085(86)90579-2
Bacterial contamination of pancreatic necrosis. A prospective clinical study.
H. Beger (1986)
10.1136/gut.30.2.223
Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial.
T. Choi (1989)
10.1016/S0016-5107(88)71372-3
Consecutive Serratia marcescens infections following endoscopic retrograde cholangiopancreatography.
T. Godiwala (1988)
10.1159/000180981
Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.
J. Bordas (1988)
10.1016/0016-5085(87)90275-7
Treatment of acute pancreatitis. Comparison of animal and human studies.
W. Steinberg (1987)
10.1055/S-2007-1021499
Present status and complications of EST in Japan.
K. Kawai (1983)
10.1055/S-2007-1021500
Experience with endoscopic sphincterotomy in the GDR. A collective study of 6 centres.
R. Arendt (1983)
Sphincter of Oddi (SO) manometry: a survey of methodology, complications and clinical application
EL JrCattau (1988)
A randomized double-blind study using CaNa,-EDTA, a phospholi
H T Tykka (1978)
The role of oxygenderived free radicals in the pathogenesis of acute pancreatitis
H Sanfey (1984)
Complications associated with endoscopic retrograde cholangiopancreatography: results of the 1974 ASGE survey. Gastrointest Endosc 1975;22:34-6
J Skjoto (1975)
10.3109/00365527909181420
A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis.
H. Goebell (1979)
10.1002/BJS.1800650514
A single‐centre double‐blind trial of Trasylol therapy in primary acute pancreatitis
C. Imrie (1978)
10.1148/64.3.325
Pancreatography; technics, principles, and observations.
H. Doubilet (1955)
Indications, contraindications and complications of ERCP
DR Ferguson (1987)
10.1016/S0016-5107(77)73457-1
Pancreatic injury following ERCP. Failure of prophylactic benefit of Trasylol.
R. Brust (1977)
10.1016/0026-0495(78)90068-9
Effect of somatostatin on the pancreatitis-like biochemical changes due to endoscopic pancreatography: preliminary report.
G. Tamás (1978)
Acute pancreatitis : experimental and clinical aspects of pathogenesis and management
G. Glazer (1988)
CT diagnosis and staging of acute pancreatitis.
E. Balthazar (1989)
PANCREATOGRAPHY WITH PARTICULAR REFERENCE TO ACTIVATION OF PANCREATIC ENZYMES.
R. Elmslie (1963)
Assessment of antimicrobial penetrance into the pancreatic juice in humans.
J. Wallace (1986)
10.1055/S-0028-1098256
Santorini's Duct--an insignificant variant from normal or an important overflow valve?
U. B. Mairose (1978)
10.1001/ARCHSURG.1971.01350080237038
Route of retrograde flow in the exocrine pancreas during ductal hypertension.
D. Bockman (1971)
10.5555/URI:PII:0039606086900759
Prospective, randomized trial of nasogastric suction in patients with acute pancreatitis.
M. Sarr (1986)
Does continuous aspiration from an end and side port in a sphincter of Oddi manometry (SOM) catheter alter recorded pressures? Gastrointest Endosc 1990;36:50&3
S Sherman (1990)
A randomized, prospective study comparing two contrast media in ERCP. Endoscopy 1987;19:201-2
WJ Cunliffe (1987)
of FOY in post-ERCP pancreatitis
(1979)
L’imprego della somatostatina dopo papilloplastica
C D’Aniello (1983)
10.1016/S0016-5107(85)72018-4
Hyperamylasemia after ERCP with ionic and non-ionic contrast media.
B. Hannigan (1985)
10.3109/00016926009172558
The influence of different contrast media for cholegraphy on blood pressure and pulse rate.
G. Saltzman (1960)
Surgical complications of endoscopic sphincterotomy.
R. Mustard (1984)
10.3109/00365527909181935
Ampicillin concentrations in pancreatic fluid bile obtained at endoscopic retrograde cholangiopancreatography (ERCP).
E. Roberts (1979)
10.1016/S0140-6736(88)90740-4
CONTROLLED TRIAL OF URGENT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AND ENDOSCOPIC SPHINCTEROTOMY VERSUS CONSERVATIVE TREATMENT FOR ACUTE PANCREATITIS DUE TO GALLSTONES
J. Neoptolemos (1988)
10.1055/S-2007-1018460
Pancreatic sphincterotomy and pancreatic endoprosthesis.
Tadasu Fuji (1985)
10.1002/BJS.1800750518
Sphincter of oddi dysfunction: Results of treatment by endoscopic sphincterotomy
J. Neoptolemos (1988)
Planned operations for
LF Hollender (1987)
Peritoneal dialysis in the treatment of acute alcoholic pancreatitis.
H. Stone (1980)
Endoscopic sphincterotomy in the management of gallstone pancreatitis.
S. van der Spuy (1981)
The immediate effects of retrograde pancreatography on the pancreas.
L. Kivisaari (1984)
10.1016/S0009-9260(85)80318-4
Demonstration of pancreatic parenchyma by digital subtraction techniques during endoscopic retrograde cholangiopancreatography.
M. Lavelle (1985)
Pancreatic pseudocysts: clinical and endoscopic experience.
J. Kolars (1989)
10.3109/00365528509088825
Indomethacin treatment of acute pancreatitis. A controlled double-blind trial.
N. Ebbehøj (1985)
Gabexat mesilat in der behandlung der akuten pankreatitis. Ergebnisse der hannoverschen multizentrischen doppelblind studie mit 50 patienten
J Freise (1986)
Pancreatic parenchymography using metrizamide
B Twomey (1982)
Recent advances in contrat agents
MA Bettmann (1986)
Controlled trial of peritoneal lavage for the treatment of severe acute pancreatitis
AD Mayer (1985)
Pancreatitis or duodenal perforation after periVaterian therapeutic endoscopic procedures: diagnosis, differentiation, and management. Surgery 1986;100:461-6
MG Sarr (1986)
Endoscopic sehincterotomy in 1000 consec;tive patients
D Vaira (1989)
10.1007/978-3-642-83027-3_12
The Significance of Bacterial Infection in Acute Pancreatitis
H. G. Beger (1987)
10.1016/S0016-5107(90)71125-X
Does continuous aspiration from an end and side port in a sphincter of Oddi manometry catheter alter recorded pressures?
S. Sherman (1990)
Hormonal and biochemical changes following endoscopic retrograde cholangio-pancreatography.
Z. Tulassay (1981)
10.1002/BJS.1800680602
British experience with duodenoscopic sphincterotomy for removal of bile duct stones
P. Cotton (1981)
Glucagon therapy of acute pancreatitis: report of a double blind study
H K Durr
The etiology of post-ERCP pancreatitis
D. Borislow (1989)
Manometric endoscopic retrograde pancreatography: technique, significance and evaluation
T Kasugai (1974)
pase-A, inhibitor in the management of human pancreatitis
(1985)
Early and late complications after endoscopic sphincterotomy for biliary lithiasis with and without the gallbladder ‘in situ.
J Escourrou (1984)
10.1136/gut.22.7.575
Changes in glucose tolerance after endoscopic retrograde cholangiopancreatography.
Z. Tulassay (1981)
10.1055/s-2007-1013011
Complications of fiberoptic gastrointestinal endoscopy--five years' experience in a central hospital.
O. Reiertsen (1987)
The Nardi test and biliary manometry in the diagnosis of pancreaticobiliary sphincter dysfunction.
J. Madura (1981)
10.1016/0002-9610(86)90027-9
Superoxide dismutase and catalase: a possible role in established pancreatitis.
K. Guice (1986)
[Effect of somatostatin on metabolic changes following ERCP ].
Z. Tulassay (1982)
Assessment of pancreatic ductal penetration of antibiotics.
J. Wallace (1984)
Hemorrhagic pancreatitis after ERCP in patients with alpha 1antitrypsin deficiency
T Svenberg (1988)
Planned operation for acute pancreatitis: the American experience
H A Reber
Hyperamylasemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography
G 175A. LaFerla (1986)
Evaluation of role the Santorini’s duct by digital subtraction endoscopic retrograde pancreatography
S Arakawa (1988)
10.1016/S0016-5107(73)73873-6
Post-endoscopy pancreatitis and hyperamylasuria.
W. D. Blackwood (1973)
10.1007/978-3-642-83027-3_8
Enzyme Activation and Liberation: Intracellular/Extracellular Events
C. Figarella (1987)
10.1097/00000658-197606000-00008
A Prospective Study to Determine the Efficacy of Antibiotics in Acute Pancreatitis
W. Finch (1976)
10.1016/S0016-5107(86)71905-6
Absorption of iodized contrast media during ERCP.
S. Ladas (1986)
10.1016/S0002-9610(88)80113-2
Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. A prospective study of 202 patients.
P. Clavien (1988)
10.2214/AJR.111.4.695
Demonstration of a retrograde pancreatic pathway: correlation of roentgenographic and electron microscopic studies.
R. L. Waldron (1971)
10.1016/S0016-5085(19)31848-7
Detection of bacterial infection of the pancreatic ducts in patients with pancreatitis and pancreatic cancer during endoscopic cannulation of the pancreatic duct.
J. Gregg (1977)
10.1055/S-0028-1098577
Prospective Study for the Prevention of Pancreatitis Following Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
H. Koch (1975)
Pancreatitis due to endoscopic biliary manometry: proceed with caution
C E King (1988)
Endoscopic therapy of pancreatic disease. In: Syllabus for therapeutic ERCP and ERCP manometry of the sphincter of Oddi
J E Geenen
Preliminary results of a multicenter double blind trial of somatostatin (S) vs. placebo (P) in acute pancreatitis (AP)
J Moreau (1986)
Acute pancreatitis: standards of conservative management
H Goebell (1987)
The effect of U.G.I. endoscopy on serum amylase
L Lifton (1975)
Preliminary results of a multicenter prospective trial of fresh frozen plasma in the treatment of acute pancreatitis
T Leese (1986)
Comparison of hypaque, omnipaque, and hexabrix for ERP
DK Reiner (1988)
10.1016/S0016-5107(88)71371-1
Severe acute pancreatitis complicating sphincter of Oddi manometry.
M. Albert (1988)
10.1016/S0140-6736(88)91718-7
Obstruction or Reflux in Gallstone-associated Acute Pancreatitis?
(1988)
10.1016/S0016-5107(88)71221-3
Endoscopic pancreatic drainage in chronic pancreatitis.
K. Huibregtse (1988)
10.5555/uri:pii:0016508580906782
Antibiotics and ERCP: in vitro activity of aminoglycosides when added to iodinated contrast agents.
J. Jendrzejewski (1980)
Effect of somatostatin on hyperamylasemia following endoscopic pancreatography.
G. Tydén (1986)
10.1002/BJS.1800720325
Successes, failures, early complications and their management following endoscopic sphincterotomy: Results in 394 consecutive patients from a single centre
T. Leese (1985)



This paper is referenced by
10.1016/S0016-5107(98)70123-3
Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography.
A. Sahai (1998)
10.1259/BJR.72.854.10365064
Biliary imaging by spiral CT cholangiography--a retrospective analysis.
Z. Sajjad (1999)
10.1016/j.gie.2010.10.039
Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review.
A. Choudhary (2011)
10.1016/0016-5085(91)90735-4
Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.
S. Sherman (1991)
10.1111/jgh.15135
Relationship Between Papilla-Related Variables and Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicenter, Prospective Study.
Xiangping Wang (2020)
The Efficacy of Preoperative Endoscopic Retrograde Cholangiopancreatography in the Detection and Clearance of Choledocholithiasis
E. Taylor (2000)
10.1007/s00464-002-4286-2
Hemolysis caused by G-6PD deficiency after a difficult and prolonged therapeutic endoscopic retrograde cholangiopancreatography
P. Katsinelos (2002)
10.1097/00006676-200408000-00018
Natural beta-carotene for the prevention of post-ERCP pancreatitis.
A. Lavy (2004)
10.1097/MPA.0b013e3181733721
The Prophylactic Effect of Somatostatin on Post-Therapeutic Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized, Multicenter Controlled Trial
K. Lee (2008)
10.1002/14651858.CD009225.PUB2
Endoscopic intervention for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
F. Tse (2012)
10.1016/S0016-5107(95)70128-1
A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group.
G. K. Johnson (1995)
10.1007/s001010050624
Die akute Pankreatitis Klassifikation – Diagnostik – Therapie
U. Sulkowski (1998)
10.1515/CCLM.2001.009
A Non-Icteric Cholecystectomized Patient with Recurrent Attacks of Right Epigastric Pain and Dilated Common Bile Duct – Do Liver Function Tests Predict Bile Duct Stones?
J. Grönroos (2001)
10.1016/S0002-9270(01)02655-7
A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis
J. Dumot (2001)
10.1067/MGE.2003.61
A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis.
G. Stefanidis (2003)
10.1007/s00464-003-4269-y
Needle–knife suprapapillary sphincterotomy avoids postprocedure pancreatitis in patients with sphincter of Oddi dysfunction of biliary type II: a report of three cases
P. Katsinelos (2003)
10.3109/10408379991249202
Magnetic resonance pancreatography (MRP).
A. Fulcher (1999)
10.1097/00006676-200205000-00001
Enzyme Leakage, Trypsinogen Activation, and Inflammatory Response in Endoscopic Retrograde Cholangiopancreatography-Induced Pancreatitis
U. Petersson (2002)
10.1067/MGE.2003.143
Predictive factors for acute pancreatitis and hyperamylasemia after endoscopic papillary balloon dilation.
M. Sugiyama (2003)
10.1016/S0016-5107(04)02013-9
Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.
P. Singh (2004)
10.3748/WJG.V13.I19.2655
Pancreatitis after endoscopic retrograde cholangio-pancreatography.
Ayman M Abdel Aziz (2007)
10.1371/journal.pone.0105795
New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation—A Retrospective Cohort Study
Ying-cai Zhang (2014)
10.1016/S0016-5107(95)70014-5
Use of corticosteroids in the prevention of post-ERCP pancreatitis.
G. R. Weiner (1995)
10.1007/978-3-642-60717-2_79
Nachweis von freien Sauerstoffradikalen nach ERCP
D. Birk (1997)
10.1111/j.1440-1746.2003.03297.x
Can somatostatin prevent post‐ERCP pancreatitis? Results of a randomized controlled trial
D. Arvanitidis (2004)
10.1007/s10620-004-9598-8
Admission Hematocrit: A Simple, Useful and Early Predictor of Severe Pancreatitis
S. Ian Gan (2004)
10.1186/1471-230X-7-6
Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials
M. Zheng (2007)
10.1155/2012/473960
Is Post-ERCP Pancreatitis a Genetically Predisposed Complication?
Konstantinos Mystakidis (2012)
10.1016/S0016-5107(94)70228-4
Outcomes of endoscopy procedures: struggling towards definitions.
P. Cotton (1994)
10.1067/MGE.2002.122614
Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
S. Manolakopoulos (2002)
10.1002/9780470987490
Advanced Digestive Endoscopy: ERCP
Peter B. Cotton (2005)
10.3748/WJG.V12.I23.3751
N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
J. Milewski (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar